A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Public ClinicalTrials.gov record NCT02290873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for midazolam, in patients undergoing a colonoscopy for diagnostic or therapeutic reasons.
Study identification
- NCT ID
- NCT02290873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 461 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2015 (Actual)
- Primary completion
- Apr 2016 (Actual)
- Completion
- Apr 19, 2016 (Actual)
- Last update posted
- Oct 20, 2020
2015 – 2016
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama | Mobile | Alabama | 36688 | — |
| Advanced Clinical Research Institute | Anaheim | California | 92801 | — |
| Precision Research Institute | Chula Vista | California | 91910 | — |
| Precision Research Institute | San Diego | California | 92114 | — |
| Borland-Grover Clinic, P.A | Jacksonville | Florida | 32256 | — |
| Indiana University Health | Indianapolis | Indiana | 46202 | — |
| Delta Research Partners Inc | Monroe | Louisiana | 71201 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Thomas Jefferson Medical College | Philadelphia | Pennsylvania | 19107 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| Gastroenterology Associates of Tidewater | Chesapeake | Virginia | 23320 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02290873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02290873 live on ClinicalTrials.gov.